Completed Heart, Stroke & Blood Brain & Nervous System

Cerebral amyloid angiopathy and intracerebral haemorrhage: community-based cohort study, biobank, and record linkage

In plain English

AI plain-English summary

A protein called amyloid gradually damages the blood vessels in the brains of some elderly people, putting them at risk of a stroke caused by bleeding inside the skull. This condition—cerebral amyloid angiopathy, or CAA—is poorly understood. Doctors cannot reliably predict who will have a brain haemorrhage, what causes it, or whether someone who survives one will have another. The research will follow a community-based group of adults who have had a brain haemorrhage, collecting their brain scans, tissue samples, and medical records. By comparing them with people who have not had a haemorrhage, and by linking their data to national health records, the team aims to identify the biological markers and risk factors that distinguish CAA-related bleeds from other types. If the research succeeds, it could lead to better diagnostic tools for identifying CAA in living patients and more accurate predictions of who is likely to suffer a second haemorrhage. That would help clinicians decide on treatments and preventive strategies. Because the population is ageing, the number of people with CAA-related brain haemorrhages is expected to rise, making this work increasingly relevant to stroke care and public health planning.

View original technical description
This research is about cerebral amyloid angiopathy, which is known as ‘CAA‘ for short. In CAA, a protein gradually damages blood vessels in the brain. CAA can be found in elderly people who are healthy, who have dementia, or who have stroke due to brain haemorrhage. This research aims to find out how CAA causes brain haemorrhages, how to recognise CAA in people with brain haemorrhage before they die, and what predicts whether someone who survives brain haemorrhage might have another one. The research will: (1) recruit adults with brain haemorrhage in one community, (2) obtain consent to collect information about them, their brain scans and their brain tissue, (3) compare them to people without brain haemorrhage in another MRC study, (4) compare different types of brain haemorrhage to eachother, and (5) study the outcome after different types of brain haemorrhage in one country. This research might benefit patients by finding out why brain haemorrhage happens, how to recognise its cause, and who is most likely to have it again. This could help identify ways of preventing brain haemorrhage in future, which will become more common as the population ages. Studying ageing is one of the MRC‘s two research priorities.

View the original record at the funder ↗

Researchers

Rustam Salman (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

The contribution of amyloid angiopathy to intracerebral haemorrhage: a clinico-radio-pathological case-control study
Cerebral haemodynamic analysis in relation to risk factors for mild cognitive impairment and Alzheimer's disease (CHARISMA)
Mapping cerebrovascular (dys)function in the early stages of Alzheimer's disease
Multimorbidity in intracerebral haemorrhage: towards personalised risk, prognosis and treatment
MRC National Survey of Health and Development Neuroimaging substudy

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.